Atlas Trials

Study to Assess the Safety, Tolerability, and Pharmacodynamics of RTA 402 in Patients With Hepatic Dysfunction

Clinical trial NCT00550849 · TERMINATED

Trial details

NCT number
NCT00550849
Sponsor
Biogen
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Liver Disease
Start date
2007-04-30
Primary completion
2007-11-30
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.